The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer

L. K. Tsoi; Цой Л. К.; V. N. Bogatyrev; Богатырев В. Н.; V. P. Letyagin; Летягин В. П.; Ya. V. Vishnevskaya; Вишневская Я. В.; A. M. Platova; Платова А. М.

doi:10.17650/1994-4098-2010-0-2-44-46

The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer

Authors: Tsoi L.K.¹, Bogatyrev V.N.¹, Letyagin V.P.¹, Vishnevskaya Y.V.¹, Platova A.M.¹
Affiliations:
1. N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Issue: No 2 (2010)
Pages: 44-46
Section: MAMMOLOGY. NEW TECHNOLOGIES
Published: 27.05.2010
URL: https://ojrs.abvpress.ru/ojrs/article/view/229
DOI: https://doi.org/10.17650/1994-4098-2010-0-2-44-46
ID: 229

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

The determination of mutant p53 and the basic parameters studied by DNA-flow cytofluorometry in combination with other clinical and morphological predictors may be used as additional prognostic criteria individually in each patient with breast cancer.